Biotech · Private company
Ribomic USA Inc
Track this companyFree. Adds Ribomic USA Inc to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AfliberceptPhase 2 · Exudative Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- RBM-007Phase 2 · Exudative Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- RBM-007 Injectable SolutionPhase 2 · Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- RBM-007 Injectable SolutionPhase 2 · Exudative Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- ShamPhase 2 · Exudative Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular DegenerationPHASE2 · COMPLETED · started Nov 3, 2020ClinicalTrials.gov NCT04640272 · fetched Nov 12, 2026
- A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular DegenerationPHASE2 · COMPLETED · started Dec 2, 2019ClinicalTrials.gov NCT04200248 · fetched Nov 12, 2026
- RBM-007 in Subjects witH ExudatIve Age-related Macular DegenerationPHASE1_PHASE2 · COMPLETED · started Aug 29, 2018ClinicalTrials.gov NCT03633084 · fetched Nov 12, 2026